Scientists dive deep into sleep Apnea's molecular secrets

NCT ID NCT07277608

Recruiting now Knowledge-focused Sponsor: Capital Medical University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to uncover the clinical features and molecular mechanisms behind obstructive sleep apnea (OSA). Researchers will analyze blood, saliva, and urine samples from 500 participants to build a multi-omics database. The goal is to identify biomarkers and treatment targets, and to understand how OSA affects long-term health, immunity, and metabolism.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could identify biomarkers and therapeutic targets for obstructive sleep apnea, potentially leading to better treatments in the future.
What could go wrong: This is an observational study, not a treatment trial. It aims to gather data, so there is no direct benefit to participants. Results may not lead to immediate clinical changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBSTRUCTIVE SLEEP APNEA

Contacts and locations

Locations

Beijing Chaoyang hospital affiliated to Capital Medical University
RECRUITING

Beijing, Beijing Municipality, 100020, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.